Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BHC | US
0.16
2.00%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
19/09/2024
8.18
8.20
8.34
7.83
Bausch Health Companies Inc. operates as a diversified pharmaceutical company. It develops manufactures and markets a range of products primarily in gastroenterology hepatology neurology dermatology international pharmaceuticals and eye health. The company operates through five segments: Salix International Solta Medical Diversified and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices branded pharmaceuticals generic pharmaceuticals and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care surgical and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. was incorporated in 2013 and is headquartered in Laval Canada.
View LessStrength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
High Short-term Volatility
Midcap (2B - 10B USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
70.4%1 month
52.9%3 months
65.7%6 months
55.8%-
1.54
18.78
-18.43
0.82
10.08
2.54
0.63
3.00B
3.00B
3.00B
-
17.60
-61.20
10.90
-2.30K
9.29
5.84
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
2.31
Range1M
2.62
Range3M
4.38
Rel. volume
1.61
Price X volume
38.45M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Amneal Pharmaceuticals Inc | AMRX | Drug Manufacturers-Specialty & Generic | 8.81 | 2.73B | 1.15% | n/a | -4742.26% |
Catalyst Pharmaceuticals Inc | CPRX | Drug Manufacturers-Specialty & Generic | 21.35 | 2.53B | 4.50% | 36.11 | 0.55% |
Amphastar Pharmaceuticals Inc | AMPH | Drug Manufacturers-Specialty & Generic | 50.09 | 2.45B | 0.62% | 15.27 | 87.00% |
PAR Technology Corporation | PAR | Drug Manufacturers-Specialty & Generic | 57.16 | 2.07B | 1.29% | n/a | 65.19% |
Supernus Pharmaceuticals Inc | SUPN | Drug Manufacturers-Specialty & Generic | 32.13 | 1.77B | 0.91% | 345.67 | 4.18% |
Harrow Health Inc | HROW | Drug Manufacturers-Specialty & Generic | 46.47 | 1.65B | 2.51% | n/a | 331.16% |
Tilray Inc | TLRY | Drug Manufacturers-Specialty & Generic | 1.78 | 1.50B | -1.11% | n/a | 11.25% |
Collegium Pharmaceutical Inc | COLL | Drug Manufacturers-Specialty & Generic | 38.93 | 1.25B | 0.39% | 14.10 | 258.31% |
OPKO Health Inc | OPK | Drug Manufacturers-Specialty & Generic | 1.59 | 1.10B | -1.85% | n/a | 19.31% |
Evolus Inc | EOLS | Drug Manufacturers-Specialty & Generic | 16.44 | 1.04B | 1.36% | n/a | 656.27% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
LCI Industries | LCII | Recreational Vehicles | 123.73 | 3.15B | 3.01% | 24.72 | 77.66% |
VeriFone Systems Inc | PAY | Building Products & Equipment | 22.21 | 2.76B | 3.45% | 82.12 | 2.10% |
Albany International Corp | AIN | Textile Manufacturing | 88.47 | 2.76B | 1.68% | 24.41 | 38.97% |
HNI Corporation | HNI | Building Products & Equipment | 53.44 | 2.52B | 0.79% | 20.98 | 76.47% |
Fox Factory Holding Corp | FOXF | Recreational Vehicles | 43.37 | 1.81B | 9.44% | 40.19 | 64.69% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 59.55 | 1.72B | 2.69% | 21.09 | 56.33% |
Steelcase Inc | SCS | Building Products & Equipment | 13.31 | 1.52B | -5.67% | 18.14 | 69.98% |
Janus International Group Inc. | JBI | Building Products & Equipment | 10.12 | 1.47B | 1.10% | 11.08 | 116.21% |
REV Group Inc | REVG | Recreational Vehicles | 27.9 | 1.45B | -1.76% | 6.25 | 63.13% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 7.1 | 1.27B | 1.28% | n/a | -571.93% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 10.08 | 16.67 | Cheaper |
Ent. to Revenue | 2.54 | 309.37 | Cheaper |
PE Ratio | - | 29.14 | - |
Price to Book | 18.78 | 12.81 | Expensive |
Dividend Yield | - | 2.80 | - |
Std. Deviation (3M) | 65.66 | 75.12 | Par |
Debt to Equity | -18.43 | -0.93 | Cheaper |
Debt to Assets | 0.82 | 0.45 | Expensive |
Market Cap | 3.00B | 5.22B | Emerging |